A prospective study of the efficacy and tolerance of a chimeric antibody to tumor necrosis factors (remicade) in severe pediatric crohn disease. (Q54776157)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A prospective study of the efficacy and tolerance of a chimeric antibody to tumor necrosis factors (remicade) in severe pediatric crohn disease. |
scientific article |
Statements
A prospective study of the efficacy and tolerance of a chimeric antibody to tumor necrosis factors (remicade) in severe pediatric crohn disease. (English)
Jean-Pierre Cezard
Nizar Nouaili
Cécile Talbotec
Jean-Gérard Gobert
Jacques Schmitz
Jean-François Mougenot
Corinne Alberti
Olivier Goulet
1 May 2003
36
5
632-636